Diamant Thaçi

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton et al. · New England Journal of Medicine · 2014 · 1.4K citations

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Marcus Harbord, Vito Annese, Stephan R. Vavricka et al. · Journal of Crohn s and Colitis · 2015 · 792 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Functional Gastrointestinal Disorder +15

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Diamant Thaçi, Eric L. Simpson, Lisa A. Beck et al. · The Lancet · 2015 · 560 citations

Allergy, Atopic Dermatitis, Allergy Medicine +7

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

Kristian Reich, Kim Papp, Andrew Blauvelt et al. · The Lancet · 2017 · 540 citations

Tildrakizumab Versus Placebo, Resurface 1, Clinical Trials +6

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

Diamant Thaçi, Andrew Blauvelt, Kristian Reich et al. · Journal of the American Academy of Dermatology · 2015 · 537 citations · Full text